Yao Chang Xu
Chief Executive Officer at ABBISKO CAYMAN LIMITED
Net worth: 35 M $ as of 29/04/2024
Yao Chang Xu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABBISKO CAYMAN LIMITED | Chief Executive Officer | 27/03/2018 | - |
| Chairman | 27/03/2018 | - | |
| Founder | 11/04/2016 | - | |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Chief Executive Officer | 11/04/2016 | - |
| Chairman | 11/04/2016 | - | |
| Founder | 11/04/2016 | - | |
| Abbisko Hong Kong Ltd. | Director/Board Member | 31/03/2018 | - |
| Wuxi Abbisko Biomedical Technology Co. Ltd. | Director/Board Member | 30/06/2020 | - |
| Abbisko Therapeutics Australia Pty Ltd. | Director/Board Member | 30/11/2020 | - |
Career history of Yao Chang Xu
Former positions of Yao Chang Xu
| Companies | Position | Start | End |
|---|---|---|---|
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Corporate Officer/Principal | 29/02/2012 | 29/02/2016 |
| Shanghai Hansoh Biomedical Co. Ltd. | Corporate Officer/Principal | 29/02/2012 | 29/02/2016 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Director/Board Member | 31/12/2005 | 29/02/2012 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/10/1993 | 31/12/2005 |
Training of Yao Chang Xu
| Nanjing University | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Statistics
International
| China | 7 |
| United States | 3 |
| Switzerland | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ABBISKO CAYMAN LIMITED | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Health Technology |
| Private companies | 6 |
|---|---|
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
| Shanghai Hansoh Biomedical Co. Ltd. | |
| Abbisko Hong Kong Ltd. | |
| Wuxi Abbisko Biomedical Technology Co. Ltd. | |
| Abbisko Therapeutics Australia Pty Ltd. |
- Stock Market
- Insiders
- Yao Chang Xu
- Experience
